Prokinetic effects of a ghrelin receptor agonist GHRP-6 in diabetic mice
Authors:
- Wen-Cai QiuWQWen-Cai Qiu
- Jun YanJYJun Yan
- Wei-Gang WangWWWei-Gang Wang
- Song YuSYSong Yu
- Zhi-Gang WangZWZhi-Gang Wang
- Kai-Xing AiKAKai-Xing Ai
Open Access
- 1 January 2008
- journal article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 14 (30) , 4795-4799
Abstract
AIM: To investigate the effects of a ghrelin receptor agonist GHRP-6 on delayed gastrointestinal transit in alloxan-induced diabetic mice. METHODS: A diabetic mouse model was established by intraperitoneal injection with alloxan. Mice were randomized into two main groups: normal mice and diabetic mice treated with GHRP-6 at doses of 0, 20, 50, 100 and 200 μg/kg ip. Gastric emptying (GE), intestinal transit (IT), and colonic transit (CT) were studied in mice after they had a phenol red meal following injection of GHRP-6. Based on the most effective GHRP-6 dosage, atropine was given at 1 mg/kg for 15 min before the GHRP-6 injection for each measurement. The mice in each group were sacrificed 20 min later and the percentages of GE, IT, and CT were calculated. RESULTS: Percentages of GE, IT, and CT were significantly decreased in diabetic mice as compared to control mice. In the diabetic mice, GHRP-6 improved both GE and IT, but not CT. The most effective dose of GHRP-6 was 200 μg/kg and atropine blocked the prokinetic effects of GHRP-6 on GE and IT. CONCLUSION: GHRP-6 accelerates delayed GE and IT, but has no effect on CT in diabetic mice. GHRP-6 may exert its prokinetic effects via the cholinergic pathway in the enteric nervous system, and therefore, has therapeutic potential for diabetic patients with delayed upper gastrointestinal transit.Keywords
This publication has 27 references indexed in Scilit:
- Ghrelin improves burn-induced delayed gastrointestinal transit in ratsAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2007
- Gastric emptying in diabetes: clinical significance and treatmentDiabetic Medicine, 2002
- Can Symptoms Discriminate Among Those With Delayed or Normal Gastric Emptying in Dysmotility-Like Dyspepsia?American Journal of Gastroenterology, 2001
- Ghrelin, an Endogenous Growth Hormone Secretagogue, Is a Novel Orexigenic Peptide That Antagonizes Leptin Action Through the Activation of Hypothalamic Neuropeptide Y/Y1 Receptor PathwayDiabetes, 2001
- Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilinGastroenterology, 2001
- In vivo and in vitro Effects of Ghrelin/Motilin-Related Peptide on Growth Hormone Secretion in the RatNeuroendocrinology, 2001
- Ghrelin Acts in the Central Nervous System to Stimulate Gastric Acid SecretionBiochemical and Biophysical Research Communications, 2001
- Ghrelin elicits a marked stimulatory effect on GH secretion in freely-moving ratsEuropean Journal of Endocrinology, 2000
- The Novel Hypothalamic Peptide Ghrelin Stimulates Food Intake and Growth Hormone SecretionEndocrinology, 2000
- Ghrelin induces adiposity in rodentsNature, 2000